High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency

Caterina I. Fanello, Corine Karema, Pamela Avellino et al. · 2008

Read High Risk of Severe Anaemia after Chlorproguanil-Dapsone+Artesunate Antimalarial Treatment in Patients with G6PD (A-) Deficiency by Caterina I. Fanello, Corine Karema, Pamela Avellino et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004031.txt.

Description

Caterina I. Fanello, Corine Karema, Pamela Avellino, and co-authors flagged a malaria drug risk in 2008. G6PD deficiency is the most common inherited enzyme defect in humans. It gives some protection against malaria itself. It also makes red cells break down under oxidant drugs.

Their PLOS ONE article reports high risk of severe anemia after one drug mix. The mix was chlorproguanil-dapsone plus artesunate. Patients carrying the G6PD A- variant faced the danger. The warning argues for screening or drug choice changes in such patients. The article came out in PLOS ONE, an open journal for science and health research.

Catalog record

CREATORCaterina I. Fanello, Corine Karema, Pamela Avellino et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004031

Browse the full library · About the Tower of Babel